Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 725.65
(1.82%)
INR 725.65
(1.82%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.11 Billion INR | -0.13% |
| 2022 | 10.12 Billion INR | -2.36% |
| 2021 | 10.37 Billion INR | 67.12% |
| 2020 | 6.2 Billion INR | -14.03% |
| 2019 | 7.22 Billion INR | 34.18% |
| 2018 | 5.38 Billion INR | -15.0% |
| 2017 | 6.33 Billion INR | 0.0% |
| 2016 | - INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.19 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 10.11 Billion INR | -0.13% |
| 2023 Q4 | 10.11 Billion INR | 0.0% |
| 2023 Q2 | 9.84 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 9.73 Billion INR | 0.0% |
| 2022 FY | 10.12 Billion INR | -2.36% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 10.12 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 10.37 Billion INR | 67.12% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 8.51 Billion INR | 0.0% |
| 2021 Q4 | 10.37 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 6.2 Billion INR | -14.03% |
| 2020 Q4 | 6.2 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 5.77 Billion INR | 0.0% |
| 2019 Q2 | 5.83 Billion INR | 0.0% |
| 2019 FY | 7.22 Billion INR | 34.18% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 7.22 Billion INR | 125.35% |
| 2019 Q3 | 3.2 Billion INR | -45.08% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 5.38 Billion INR | -15.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 6.02 Billion INR | 0.0% |
| 2018 Q4 | 5.38 Billion INR | 0.0% |
| 2017 Q4 | 6.33 Billion INR | 18.24% |
| 2017 Q3 | 5.35 Billion INR | 0.0% |
| 2017 FY | 6.33 Billion INR | 0.0% |
| 2016 FY | - INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | -607.087% |
| Ind-Swift Limited | 10.13 Billion INR | 0.246% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -203.914% |
| Sakar Healthcare Limited | 793.51 Million INR | -1174.706% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 84.784% |
| Innova Captab Limited | 2.45 Billion INR | -312.682% |
| Divi's Laboratories Limited | 30 Million INR | -33616.667% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -21897.738% |
| Morepen Laboratories Limited | 289.99 Million INR | -3388.027% |
| Mankind Pharma Limited | 2.07 Billion INR | -388.241% |
| Sequent Scientific Limited | 4.87 Billion INR | -107.405% |
| Wanbury Limited | 1.16 Billion INR | -768.355% |
| Laurus Labs Limited | 25.77 Billion INR | 60.755% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -59.157% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -5798.647% |
| Alembic Limited | 91.5 Million INR | -10954.645% |
| Hikal Limited | 8.17 Billion INR | -23.719% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -97.112% |
| Neuland Laboratories Limited | 953.89 Million INR | -960.388% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -167.834% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 17.826% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -2987.607% |
| Themis Medicare Limited | 957.92 Million INR | -955.931% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -25.777% |
| Lupin Limited | 29.21 Billion INR | 65.381% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -58425.719% |
| Wockhardt Limited | 23.56 Billion INR | 57.067% |
| Vaishali Pharma Limited | 134.91 Million INR | -7397.146% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -254.601% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -11213.052% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 72.394% |
| FDC Limited | 205.18 Million INR | -4829.698% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 49.476% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -3096.246% |
| Eris Lifesciences Limited | 27.81 Billion INR | 63.632% |
| Venus Remedies Limited | 413.3 Million INR | -2347.375% |
| ZIM Laboratories Limited | 1.08 Billion INR | -829.479% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -913.12% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -51245.178% |
| Shilpa Medicare Limited | 9.37 Billion INR | -7.906% |
| Albert David Limited | 33.24 Million INR | -30328.375% |
| Ajanta Pharma Limited | 352.8 Million INR | -2767.063% |
| Hester Biosciences Limited | 2.44 Billion INR | -313.908% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -1456.24% |
| Gufic Biosciences Limited | 3.32 Billion INR | -203.831% |
| Windlas Biotech Limited | 36.41 Million INR | -27680.829% |
| Procter & Gamble Health Limited | 95.6 Million INR | -10480.544% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -3126.238% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -926.982% |
| Granules India Limited | 13.15 Billion INR | 23.084% |
| Aarti Drugs Limited | 5.64 Billion INR | -79.258% |
| Bal Pharma Limited | 1.39 Billion INR | -624.319% |
| Alkem Laboratories Limited | 14.18 Billion INR | 28.688% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 69.102% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -94716.273% |
| Medicamen Biotech Limited | 308.17 Million INR | -3182.258% |
| Unichem Laboratories Limited | 2.47 Billion INR | -308.663% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -4047.311% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -230362.52% |
| Valiant Laboratories Limited | 767.08 Million INR | -1218.63% |
| Orchid Pharma Limited | 1.35 Billion INR | -648.258% |
| Medico Remedies Limited | 80.5 Million INR | -12464.593% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -5985.455% |
| Ipca Laboratories Limited | 14.38 Billion INR | 29.677% |
| Brooks Laboratories Limited | 56.41 Million INR | -17828.357% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -1295.43% |
| Piramal Enterprises Limited | 535.85 Billion INR | 98.112% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 74.851% |
| NATCO Pharma Limited | 3.71 Billion INR | -172.495% |
| Suven Life Sciences Limited | 7.09 Million INR | -142425.011% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -422.93% |
| Strides Pharma Science Limited | 25.16 Billion INR | 59.811% |
| Indoco Remedies Limited | 6.71 Billion INR | -50.53% |
| Alpa Laboratories Limited | 52.46 Million INR | -19179.52% |
| Lasa Supergenerics Limited | 220.76 Million INR | -4481.857% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -1554.129% |